C07C 281/08
The other nitrogen atom being further doubly-bound to a carbon atom
Official title: the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones
C07C281/08 (The other nitrogen atom being further doubly-bound to a carbon atom) appears on 83 US grants and 47 published applications in this corpus.
Search patents in C07C- Granted patents
- 83
- Published applications
- 47
- Assignees
- 50
- Inventors
- 239
- Latest grant
- 11 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 7 | 0 |
| 1997 | 6 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 5 | 2 |
| 2002 | 8 | 3 |
| 2003 | 4 | 6 |
| 2004 | 2 | 2 |
| 2005 | 2 | 2 |
| 2006 | 2 | 1 |
| 2007 | 1 | 2 |
| 2008 | 2 | 1 |
| 2009 | 2 | 1 |
| 2010 | 2 | 1 |
| 2011 | 0 | 3 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 1 | 1 |
| 2015 | 2 | 2 |
| 2016 | 2 | 3 |
| 2017 | 0 | 1 |
| 2018 | 0 | 4 |
| 2019 | 5 | 3 |
| 2020 | 3 | 1 |
| 2021 | 0 | 2 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Therapeutic compounds11 Jun 2024US 12,006,294 B2Regents of the University of Minnesota
- Manufacturing method for high-purity cyclohexenone long-chain alcohol1 Nov 2022US 11,485,696 B2Taiho Pharmaceutical Co., Ltd.
- Protective molecules against anthrax toxin4 Aug 2020US 10,730,848 B2The Regents of the University of California
- (Thio, oxo, and seleno) semicarbazone derivatives and their use for treating cancer31 Mar 2020US 10,604,480 B2Rutgers, The State University of New Jersey
- (Thio, oxo and seleno) semicarbazone complexes with zinc and their use for treating cancer31 Mar 2020US 10,604,481 B2Rutgers, The State University of New Jersey
- Antiozonant compositions and methods25 Jun 2026US 2026/0176383 A1
- Compounds and methods to target glucose-stimulated phosphohistidine signaling and esophageal cancer growth28 Dec 2023US 2023/0416209 A1
- Therapeutic agent for corneal diseases5 May 2022US 2022/0133659 A1Nissan Chemical Corporation
- Kinase inhibitor19 Aug 2021US 2021/0253518 A1Nissan Chemical Corporation
- Manufacturing method for high-purity cyclohexenone long-chain alcohol8 Apr 2021US 2021/0101859 A1Taiho Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates74US 6,235,936 B1Massachusetts Institute of Technology · 2001
- Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates64US 6,465,693 B2Massachusetts Institute of Technology · 2002
- Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof61US 6,613,803 B1Euro-Celtique S. A. · 2003
- Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof61US 6,638,947 B2Euro-Celtique S. A. · 2003
- Anthelmintic N'-substituted-N,N'-disubstitutedhydrazines56US 5,424,333 ARohm and Haas Company · 1995